Clinical Trials Directory

Trials / Completed

CompletedNCT04634812

Mass Balance Study of KBP-5074 in Healthy Male Subjects

A Phase 1, Open-label, Study of the Absorption, Metabolism, and Excretion of [14C]-KBP-5074 Following a Single Oral Dose in Healthy Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
7 (actual)
Sponsor
KBP Biosciences · Industry
Sex
Male
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This is a Phase 1, open-label, nonrandomized, single-dose mass balance and metabolite identification study in healthy male subjects.

Conditions

Interventions

TypeNameDescription
DRUGKBP-5074a single oral dose of \[14C\]-KBP-5074

Timeline

Start date
2020-12-03
Primary completion
2020-12-23
Completion
2020-12-23
First posted
2020-11-18
Last updated
2025-12-16

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04634812. Inclusion in this directory is not an endorsement.

Mass Balance Study of KBP-5074 in Healthy Male Subjects (NCT04634812) · Clinical Trials Directory